PHAR · Pharming Group N.V. · Debt
$12.13
-0.13 (-1.06%)
At close · Oct 29
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Market Cap
$859.95M
Shares
70.78M
Volume · Oct 29
12.43K
Avg daily vol (3M)
25.01K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current bonds issued, including current portion of noncurrent bonds | 2025-12-31 | USD 5,336,000 | 20-F/A filed 2026-04-13 |
| Lease liabilities | 2025-12-31 | USD 17,719,000 | 20-F/A filed 2026-04-13 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent bonds issued | 2025-12-31 | USD 92,719,000 | 20-F/A filed 2026-04-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.